94 related articles for article (PubMed ID: 24867647)
1. Model to predict the survival benefit of radiation for patients with rhabdomyosarcoma after surgery: a population-based study.
Shen W; Sakamoto N; Yang L
Int J Oncol; 2014 Aug; 45(2):549-57. PubMed ID: 24867647
[TBL] [Abstract][Full Text] [Related]
2. Surveillance, epidemiology, and end results-based analysis of the impact of preoperative or postoperative radiotherapy on survival outcomes for T3N0 rectal cancer.
Peng LC; Milsom J; Garrett K; Nandakumar G; Coplowitz S; Parashar B; Nori D; Clifford Chao KS; Wernicke AG
Cancer Epidemiol; 2014 Feb; 38(1):73-8. PubMed ID: 24491755
[TBL] [Abstract][Full Text] [Related]
3. Prediction model for estimating the survival benefit of adjuvant radiotherapy for gallbladder cancer.
Wang SJ; Fuller CD; Kim JS; Sittig DF; Thomas CR; Ravdin PM
J Clin Oncol; 2008 May; 26(13):2112-7. PubMed ID: 18378567
[TBL] [Abstract][Full Text] [Related]
4. Prognostic factors and surgical treatment guidelines for children with rhabdomyosarcoma of the perineum or anus: a report of Intergroup Rhabdomyosarcoma Studies I through IV, 1972 through 1997.
Blakely ML; Andrassy RJ; Raney RB; Anderson JR; Wiener ES; Rodeberg DA; Paidas CN; Lobe TE; Crist WM;
J Pediatr Surg; 2003 Mar; 38(3):347-53. PubMed ID: 12632347
[TBL] [Abstract][Full Text] [Related]
5. The role of adjuvant radiation therapy for resected stage III thymoma: a population-based study.
Weksler B; Shende M; Nason KS; Gallagher A; Ferson PF; Pennathur A
Ann Thorac Surg; 2012 Jun; 93(6):1822-8; discussion 1828-9. PubMed ID: 22551847
[TBL] [Abstract][Full Text] [Related]
6. Nomogram for Individualized Prediction and Prognostic Factors for Survival in Patients with Primary Spinal Chordoma: A Population-Based Longitudinal Cohort Study.
Huang JF; Chen D; Sang CM; Zheng XQ; Lin JL; Lin Y; Ni WF; Wang XY; Li YM; Wu AM
World Neurosurg; 2019 Aug; 128():e603-e614. PubMed ID: 31054340
[TBL] [Abstract][Full Text] [Related]
7. Comparing adult and pediatric rhabdomyosarcoma in the surveillance, epidemiology and end results program, 1973 to 2005: an analysis of 2,600 patients.
Sultan I; Qaddoumi I; Yaser S; Rodriguez-Galindo C; Ferrari A
J Clin Oncol; 2009 Jul; 27(20):3391-7. PubMed ID: 19398574
[TBL] [Abstract][Full Text] [Related]
8. The role for adjuvant radiotherapy in the treatment of hemangiopericytoma: a Surveillance, Epidemiology, and End Results analysis.
Sonabend AM; Zacharia BE; Goldstein H; Bruce SS; Hershman D; Neugut AI; Bruce JN
J Neurosurg; 2014 Feb; 120(2):300-8. PubMed ID: 24286142
[TBL] [Abstract][Full Text] [Related]
9. Prognostic model for predicting overall survival in children and adolescents with rhabdomyosarcoma.
Yang L; Takimoto T; Fujimoto J
BMC Cancer; 2014 Sep; 14():654. PubMed ID: 25189734
[TBL] [Abstract][Full Text] [Related]
10. Survival outcomes in resected extrahepatic cholangiocarcinoma: effect of adjuvant radiotherapy in a surveillance, epidemiology, and end results analysis.
Vern-Gross TZ; Shivnani AT; Chen K; Lee CM; Tward JD; MacDonald OK; Crane CH; Talamonti MS; Munoz LL; Small W
Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):189-98. PubMed ID: 20971573
[TBL] [Abstract][Full Text] [Related]
11. Adjuvant radiation therapy increases overall survival in node-positive gastric cancer patients with aggressive surgical resection and lymph node dissection: a SEER database analysis.
Shridhar R; Dombi GW; Weber J; Hoffe SE; Meredith K; Konski A
Am J Clin Oncol; 2012 Jun; 35(3):216-21. PubMed ID: 21378540
[TBL] [Abstract][Full Text] [Related]
12. A national propensity-adjusted analysis of adjuvant radiotherapy in the treatment of resected pancreatic adenocarcinoma.
McDade TP; Hill JS; Simons JP; Piperdi B; Ng SC; Zhou Z; Kadish SP; Fitzgerald TJ; Tseng JF
Cancer; 2010 Jul; 116(13):3257-66. PubMed ID: 20564625
[TBL] [Abstract][Full Text] [Related]
13. Cancer-specific mortality and competing mortality in patients with head and neck squamous cell carcinoma: a competing risk analysis.
Shen W; Sakamoto N; Yang L
Ann Surg Oncol; 2015 Jan; 22(1):264-71. PubMed ID: 25074664
[TBL] [Abstract][Full Text] [Related]
14. Adjuvant radiotherapy improves overall survival for patients with lymph node-positive head and neck squamous cell carcinoma.
Lavaf A; Genden EM; Cesaretti JA; Packer S; Kao J
Cancer; 2008 Feb; 112(3):535-43. PubMed ID: 18076014
[TBL] [Abstract][Full Text] [Related]
15. A nomogram to predict individual prognosis in node-negative breast carcinoma.
Mazouni C; Spyratos F; Romain S; Fina F; Bonnier P; Ouafik LH; Martin PM
Eur J Cancer; 2012 Nov; 48(16):2954-61. PubMed ID: 22658808
[TBL] [Abstract][Full Text] [Related]
16. Oncologic benefit of tonsillectomy in stage I and II tonsil cancer: a surveillance epidemiology and end results database review.
Holliday MA; Tavaluc R; Zhuang T; Wang H; Davidson B
JAMA Otolaryngol Head Neck Surg; 2013 Apr; 139(4):362-6. PubMed ID: 23599071
[TBL] [Abstract][Full Text] [Related]
17. Nomogram for predicting the benefit of neoadjuvant chemoradiotherapy for patients with esophageal cancer: a SEER-Medicare analysis.
Eil R; Diggs BS; Wang SJ; Dolan JP; Hunter JG; Thomas CR
Cancer; 2014 Feb; 120(4):492-8. PubMed ID: 24194477
[TBL] [Abstract][Full Text] [Related]
18. Does adjuvant radiotherapy benefit patients with diffuse-type gastric cancer? Results from the Surveillance, Epidemiology, and End Results database.
Stessin AM; Sison C; Schwartz A; Ng J; Chao CK; Li B
Cancer; 2014 Nov; 120(22):3562-8. PubMed ID: 25043858
[TBL] [Abstract][Full Text] [Related]
19. The benefit of adjuvant radiation therapy in single-node-positive squamous cell vulvar carcinoma.
Parthasarathy A; Cheung MK; Osann K; Husain A; Teng NN; Berek JS; Kapp DS; Chan JK
Gynecol Oncol; 2006 Dec; 103(3):1095-9. PubMed ID: 16889821
[TBL] [Abstract][Full Text] [Related]
20. Population-based outcome of stage IA-IIA resected gastric adenocarcinoma: who should get adjuvant treatment?
Gold JS; Al Natour RH; Saund MS; Yoon C; Sharma AM; Huang Q; Boosalis VA; Whang EE
Ann Surg Oncol; 2013 Jul; 20(7):2304-10. PubMed ID: 23344580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
